Healthcare product and device company Abbott Laboratories (NYSE:ABT) fell short of the markets revenue expectations in Q4 ...

Abbott Laboratories (NYSE:ABT) shares fell about 4.8% after the company reported fourth-quarter results that met earnings ...

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.3% in the afternoon session after the company reported fourth-quarter revenue that missed Wall Street's ...

European shares were higher today. The eurozone's STOXX 600 gained 1.09%, while Spain's IBEX 35 Index rose 1.01%. London's FTSE 100 rose 0.26%, Germany's DAX gained 1.19% and France's CAC 40 gained ...

Abbott received CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms. Shares of Abbott fell 0.3% to close at $120.73 on Wed ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results tomorrow before the ...

The Medical Devices business remained a standout performer at Abbott, with Q4 sales up 12.3% to $5.68 billion. Abbott ...

Investing.com -- Abbott Laboratories (NYSE:ABT) reported fourth-quarter earnings that met expectations but missed on revenue, ...

Abbott Laboratories (NYSE: ABT) doesn’t just pay dividends. It grows them. For 52 consecutive years. That’s Dividend King ...

We recently compiled a list of the 10 Best Investments During A Recession. The seventh stock on our list of best investments ...

On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA System to treat patients with atrial fibrillation, or AFib. The company ...

Dividend aristocrats get plenty of attention, but most of the time the spotlight falls on the big names like Johnson & ...